Every day a New Zealander is diagnosed with ovarian cancer. Your support helps us ensure that every day – New Zealand’s best and brightest scientists can keep working to extend lives and find a cure.
The care cancer specialists can deliver is only as good a job as the tools they have at hand. As the least survivable gynaecological cancer ovarian cancer needs better tools. Our grantees are exceptional individuals striving to advance ovarian cancer survival through research to improve treatment and care.
Since 2018 we’ve partnered with the Graci Foundation – New Zealand’s Gynaecological Cancer Research Charity – to administer our ovarian cancer grants alongside their gynaecological cancer grants. They use their expertise to ensure the donations we raise, fund the best ovarian cancer research possible.
Targeted molecular profiling of high-grade serous/endometrioid ovarian cancer in New Zealand patients
Combination of re-purposed iron-chelating and anti-malarial drugs to overcome autophagy cell survival in ovarian cancer
Investigation of dual Src/MEK targeting in low-grade serous ovarian cancer (as a part of SMILE study – Src MEK Inhibition for Low-grade ovarian cancer Elimination)
Correlating molecular alterations in low-grade serous carcinoma (LGSC) to patient outcomes in New Zealand
Investigating novel therapeutic targeted drugs in low-grade serous ovarian cancer that is effected by tumour microenvironment